Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.740
+0.010 (0.58%)
At close: Jun 13, 2025, 4:00 PM
1.808
+0.068 (3.93%)
After-hours: Jun 13, 2025, 6:58 PM EDT
Immutep Employees
Immutep had 31 employees as of June 30, 2014.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$97,395
Profits / Employee
-$875,690
Market Cap
242.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2014 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
IMMP News
- 17 days ago - Immutep's Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma - GlobeNewsWire
- 4 weeks ago - Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo - Benzinga
- 5 weeks ago - Immutep Limited: Surging On Positive Head And Neck Data - Seeking Alpha
- 2 months ago - Immutep to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Immutep Quarterly Activities Report Q2 FY25 - GlobeNewsWire
- 4 months ago - Immutep Limited: Continuing To Make The Case For Eftilagimod - Seeking Alpha
- 6 months ago - Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewsWire
- 6 months ago - Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024 - GlobeNewsWire